يعرض 1 - 10 نتائج من 54 نتيجة بحث عن '"A Gelibter"', وقت الاستعلام: 1.03s تنقيح النتائج
  1. 1
    Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study

    المؤلفون: Maria Vittoria Pensieri, Ettore D'Argento, Giovanni Mansueto, Lorenza Landi, Mario Occhipinti, Diego Cortinovis, Robin Cornelissen, Diego Signorelli, Lorenzo Antonuzzo, Gabriele Minuti, Valerio Maria Napoli, Corrado Ficorella, Francesco Grossi, Raffaele Giusti, Cinzia Baldesarri, Vincenzo Di Noia, Giampiero Porzio, Alfredo Addeo, Luigi Della Gravara, Vincenzo Sforza, Serena Ricciardi, Paola Bordi, Francesca Rastelli, Alessandro Inno, Giuseppe Luigi Banna, Giovanni Rossi, Michele De Tursi, Matteo Santoni, Rita Chiari, Alessandro De Toma, Olga Nigro, Andrea De Giglio, Clelia Donisi, Luca Cantini, Fabrizio Citarella, Alessio Cortellini, Michele Montrone, Alain Gelibter, Gianmarco Leone, Alessandro Follador, Annamaria Catino, Federica Zoratto, Marco Filetti, Pietro Di Marino, Giulio Metro, Alex Friedlaender, Alessandro Leonetti, Rossana Berardi, Maria Rita Migliorino, Marco Russano, Katia Cannita

    المساهمون: Pulmonary Medicine, Cortellini A., De Giglio A., Cannita K., Cortinovis D.L., Cornelissen R., Baldessari C., Giusti R., D'Argento E., Grossi F., Santoni M., Catino A., Berardi R., Sforza V., Rossi G., Antonuzzo L., Di Noia V., Signorelli D., Gelibter A., Occhipinti M.A., Follador A., Rastelli F., Chiari R., Gravara L.D., Inno A., De Tursi M., Di Marino P., Mansueto G., Zoratto F., Filetti M., Montrone M., Citarella F., Pensieri M.V., Russano M., Cantini L., Nigro O., Leonetti A., Bordi P., Minuti G., Landi L., De Toma A., Donisi C., Ricciardi S., Migliorino M.R., Napoli V.M., Leone G., Metro G., Banna G.L., Friedlaender A., Addeo A., Ficorella C., Porzio G.

    المصدر: Thoracic Cancer, Vol 12, Iss 6, Pp 880-889 (2021)
    Thoracic Cancer, 12(6), 880-889. Blackwell Publishing
    Thoracic Cancer

    مصطلحات موضوعية: Male, non‐small cell lung cancer, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, First line, Respiratory System, Pembrolizumab, immunotherapy, non-small cell lung cancer, pembrolizumab, smoking, tobacco, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Chemotherapy, Science & Technology, business.industry, Hazard ratio, Original Articles, General Medicine, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Former Smoker, Survival Analysis, Lung Neoplasm, 030104 developmental biology, Case-Control Studies, 030220 oncology & carcinogenesis, Cohort, Female, Original Article, Smoking status, Case-Control Studie, business, Life Sciences & Biomedicine, Human

    وصف الملف: Print-Electronic; application/pdf; ELETTRONICO

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a176bfa7c423e7af5a594a66671b7acaTest
    https://doi.org/10.1111/1759-7714.13852Test


    أضف إلى المفضلة
  2. 2
    Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy

    المؤلفون: Giampiero Porzio, Luigi Della Gravara, Carlo Genova, Danilo Rocco, Luca Cantini, Sebastiano Buti, Sergio Bracarda, Marco Filetti, Alessandro Tuzi, R. Bisonni, Giulio Metro, Claudia Bareggi, Francesco Grossi, Francesca Mazzoni, Alfredo Addeo, David J. Pinato, Emilio Bria, Giovanni Mansueto, Vincenzo Adamo, Joachim G.J.V. Aerts, Raffaele Giusti, Diego Signorelli, Alessio Cortellini, Miriam Grazia Ferrara, Giorgia Guaitoli, Lorenza Landi, Corrado Ficorella, Gabriele Minuti, Fabiana Perrone, Fabrizio Citarella, Melissa Bersanelli, Giuseppe Luigi Banna, Emanuela Olmetto, Marina Chiara Garassino, Marco Siringo, Alain Gelibter, Michele De Tursi, Marco Russano, Giulia Mazzaschi, Gian Paolo Spinelli, Vincenzo Sforza, Luca Carmisciano, Rita Chiari, Katia Cannita, Fabrizio Tabbò, Diego Cortinovis, Alessandro De Toma, Serena Ricciardi, Stefania Gori, Olga Nigro, Mariangela Torniai, Rossana Berardi, Marcello Tiseo, Maria Rita Migliorino, Fausto Barbieri, Alessandro Follador, Alessandro Russo, Massimo Di Maio, Pietro Di Marino, Alex Friedlaender, Federica Zoratto

    المساهمون: Pulmonary Medicine

    المصدر: European Journal of Cancer, 150, 224-231. Elsevier Ltd.

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Pembrolizumab, Predictive score, 0302 clinical medicine, Adrenal Cortex Hormones, Risk Factors, Carcinoma, Non-Small-Cell Lung, Monoclonal, Drug Interactions, Concomitant medications, First-line, Immunotherapy, Non–small-cell lung cancer, Non-Small-Cell Lung, Aged, Anti-Bacterial Agents, Antibodies, Monoclonal, Humanized, Clinical Decision-Making, Female, Humans, Immune Checkpoint Inhibitors, Italy, Patient Selection, Polypharmacy, Predictive Value of Tests, Progression-Free Survival, Proton Pump Inhibitors, Reproducibility of Results, Retrospective Studies, Risk Assessment, Decision Support Techniques, Humanized, 030220 oncology & carcinogenesis, Cohort, Cohort study, medicine.medical_specialty, Antibodies, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Progression-free survival, Lung cancer, Chemotherapy, business.industry, Carcinoma, Case-control study, medicine.disease, 030104 developmental biology, Concomitant, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f064f47ad0d04a4c5a32c0434d5b0ba1Test
    https://doi.org/10.1016/j.ejca.2021.03.041Test


    أضف إلى المفضلة
  3. 3
    Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis

    المؤلفون: G. Comi, Mauro Comola, Raffaella Chieffo, Letizia Leocani, Stefano Gelibter, Marco Pisa, Antonino Giordano

    المساهمون: Pisa, M., Chieffo, R., Giordano, A., Gelibter, S., Comola, M., Comi, G., Leocani, L.

    المصدر: Clinical Neurophysiology. 131:401-405

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Multiple Sclerosis, 050105 experimental psychology, 03 medical and health sciences, 0302 clinical medicine, Physical medicine and rehabilitation, Physiology (medical), Reaction Time, medicine, Humans, Multiple sclerosi, 0501 psychology and cognitive sciences, Motor evoked potential, Remyelination, Latency (engineering), Evoked potential, Progressive multiple sclerosis, Dexterity, Disability, Electromyography, business.industry, Multiple sclerosis, 05 social sciences, Middle Aged, Evoked Potentials, Motor, medicine.disease, Sensory Systems, Treatment Outcome, medicine.anatomical_structure, Neurology, Corticospinal tract, Cohort, Arm, Ambulation, Upper limb, Female, Neurology (clinical), business, 030217 neurology & neurosurgery

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f589ba37ac2631773a80a6f9d32f4796Test
    https://doi.org/10.1016/j.clinph.2019.11.024Test


    أضف إلى المفضلة
  4. 4
    A Comparison Between First-, Second- and Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small-Cell Lung Cancer and Brain Metastases

    المؤلفون: Giuseppe Luigi Banna, Alessio Cortellini, Alain Gelibter, Sunil Daryanani, Ornella Cantale, Dario Giuffrida, Alex Friedlaender, Salvatore Caponnetto, Fabio Gomes, Alfredo Addeo

    المصدر: Journal of Molecular Pathology. 2:1-10

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, biology, business.industry, Afatinib, medicine.disease, Lower risk, respiratory tract diseases, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Gefitinib, 030220 oncology & carcinogenesis, Internal medicine, medicine, biology.protein, Osimertinib, Erlotinib, Epidermal growth factor receptor, Progression-free survival, Lung cancer, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fd59b01e17f3675f2739354a4395bc9fTest
    https://doi.org/10.3390/jmp2010001Test


    أضف إلى المفضلة
  5. 5
    Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter study

    المؤلفون: Michele Milella, Francesco Cognetti, Michela Roberto, Fabiana Letizia Cecere, Biagio Ricciuti, Viola Barucca, Maria Bassanelli, Paolo Marchetti, Silvana Giacinti, Alain Gelibter, Mario Santarelli, Enzo Maria Ruggeri, Anna Ceribelli, Enrico Cortesi, Rita Chiari, Diana Giannarelli

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, combined modality therapy, medicine.medical_treatment, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, Carcinoma, Non-Small-Cell Lung, Medicine, Combined Modality Therapy, Humans, 030212 general & internal medicine, Lung cancer, radiotherapy, Retrospective Studies, business.industry, General Medicine, Immunotherapy, medicine.disease, immunotherapy, lung cancer, radioimmunotherapy, Radiation therapy, Nivolumab, 030220 oncology & carcinogenesis, Radioimmunotherapy, Observational study, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e39a5f5f3cd3b0bd0d890188e6007d6Test
    https://hdl.handle.net/11573/1676730Test


    أضف إلى المفضلة
  6. 6
    Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

    المؤلفون: Giampiero Porzio, Michele De Tursi, Paolo A. Ascierto, Tea Zeppola, Marcello Tiseo, Daniele Santini, Sebastiano Buti, Francesca Rastelli, Sergio Bracarda, Rossana Berardi, Riccardo Marconcini, Clara Natoli, Andrea De Giglio, Rita Chiari, Cecilia Anesi, Marco Filetti, Federica Zoratto, Rosa Rita Silva, Melissa Bersanelli, Alessio Cortellini, Paolo Marchetti, Raffaele Giusti, Andrea Botticelli, Federica De Galitiis, Alain Gelibter, Corrado Ficorella, Claudia Mosillo, Vito Vanella, Maria Rita Migliorino, Marianna Tudini, Fabiana Perrone, Francesco Atzori, Marco Russano, Biagio Ricciuti, Katia Cannita, Silvia Rinaldi, Domenico Mallardo, Maria Giuseppa Vitale

    المصدر: European Journal of Cancer. 128:17-26

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Programmed Cell Death 1 Receptor, Overweight, Severity of Illness Index, B7-H1 Antigen, Body Mass Index, Antineoplastic Agents, Immunological, 0302 clinical medicine, Risk Factors, Immune-related adverse events, Renal cell carcinoma, Neoplasms, 80 and over, Cancer, Aged, 80 and over, Incidence, Middle Aged, Immunological, BMI, Checkpoint inhibitors, Immunotherapy, Obesity, PD-1/PD-L1, 030220 oncology & carcinogenesis, Female, medicine.symptom, Underweight, Adult, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Aged, Humans, Retrospective Studies, Young Adult, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Adverse effect, business.industry, Retrospective cohort study, medicine.disease, 030104 developmental biology, business, Body mass index

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88fb86092cd1e482e67c1ae96e50babTest
    https://doi.org/10.1016/j.ejca.2019.12.031Test


    أضف إلى المفضلة
  7. 7
    Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression >= 50% and Their Relationship With Clinical Outcomes

    المؤلفون: Raffaele Giusti, Giorgia Guaitoli, Mario Occhipinti, Diego Cortinovis, Ornella Cantale, Luca Cantini, Cinzia Baldessari, Alessio Cortellini, Francesco Grossi, Linda Pettoruti, Vincenzo Sforza, Giovanni Mansueto, Francesco Passiglia, Francesca Mazzoni, Lorenza Landi, Alain Gelibter, Melissa Bersanelli, Daniele Santini, Paolo Marchetti, Alessandro Morabito, Alessandro Leonetti, Marianna Tudini, Serena Ricciardi, Fabrizio Citarella, Ettore D'Argento, Francesca Rastelli, Matteo Santoni, Vincenzo Di Noia, Giampiero Porzio, Robert A. Belderbos, Claudia Proto, Simona Scodes, Marianna Macerelli, Marco Filetti, Joachim G.J.V. Aerts, Diego Signorelli, Luigi Della Gravara, Carlo Genova, Danilo Rocco, Lorenzo Antonuzzo, Alessandro Tuzi, Cristina Cecchi, Luca Sala, Corrado Ficorella, Marco De Filippis, Giuseppe Luigi Banna, Alessandro Inno, Mariangela Torniai, Pamela Pizzutilo, Emilio Bria, Maria Giovanna Dal Bello, Domenico Galetta, Federico Cappuzzo, Federica Bertolini, Rossana Berardi, Maria Rita Migliorino, Miriam Grazia Ferrara, Clelia Donisi, Rita Chiari, Alessandro De Toma, Olga Nigro, Michele Ghidini, Annamaria Catino, Alfredo Addeo, Federica Zoratto, Alessandro Follador, Pietro Di Marino, Alex Friedlaender, Marco Russano, Biagio Ricciuti, Katia Cannita

    المساهمون: Pulmonary Medicine

    المصدر: Clinical Lung Cancer, 21(6), 498-508.e2. Elsevier

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, PD-L1, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, First line, irAEs, NSCLC, Pembrolizumab, Immune checkpoint inhibitors, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Adverse effect, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, biology, business.industry, Middle Aged, medicine.disease, Prognosis, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, biology.protein, Carcinoma, Squamous Cell, Pd l1 expression, Female, business, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531621b29708da404fb5e5130661d486Test
    https://pure.eur.nl/en/publications/1e14e673-632c-43f9-9fef-78675b6ec8e3Test


    أضف إلى المفضلة
  8. 8
    Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?

    المؤلفون: Mario Orrico, Gloria Dalla Costa, Paolo Preziosa, Marco Pisa, Stefano Gelibter, Massimo Filippi, Roberto Furlan, Francesca Sangalli, Vittorio Martinelli, Tommaso Croese

    المساهمون: Gelibter, S., Pisa, M., Croese, T., Dalla Costa, G., Orrico, M., Preziosa, P., Sangalli, F., Martinelli, V., Furlan, R., Filippi, M.

    مصطلحات موضوعية: medicine.medical_specialty, Neurology, Multiple Sclerosis, Neutrophils, Contrast Media, Gadolinium, CSF, Neurofilament, Gastroenterology, Multiple sclerosis, 03 medical and health sciences, 0302 clinical medicine, Neurofilament Proteins, Internal medicine, Medicine, Humans, 030212 general & internal medicine, Lymphocytes, Neutrophil to lymphocyte ratio, Neutrophil-to-lymphocyte ratio, Neuroradiology, Retrospective Studies, Inflammation, Clinically isolated syndrome, business.industry, Biomarker, Extracellular vesicles, medicine.disease, Neuro-inflammation, Cohort, Biomarker (medicine), Neurology (clinical), Sample collection, business, 030217 neurology & neurosurgery, Biomarkers, Microvesicles

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2370b91424c6605d4ac2cc3a23083eb2Test


    أضف إلى المفضلة
  9. 9
    Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?

    المؤلفون: Mario Orrico, Agostino Nozzolillo, Francesca Sangalli, Paolo Preziosa, Massimo Filippi, Stefano Gelibter, Lucia Moiola

    المساهمون: Orrico, M., Nozzolillo, A., Gelibter, S., Sangalli, F., Preziosa, P., Filippi, M., Moiola, L.

    المصدر: Journal of Neurology

    مصطلحات موضوعية: Cardiovascular event, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), 1-phosphate, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Sphingosine, Internal medicine, Humans, Medicine, 030212 general & internal medicine, Sphingosine-1-phosphate, Atrioventricular Block, Adverse effect, Pandemics, Sphingosine 1-phosphate, Original Communication, Fingolimod Hydrochloride, SARS-CoV-2, business.industry, Multiple sclerosis, COVID-19, Sphingosine , Fingolimod, medicine.disease, Discontinuation, Neurology, chemistry, Cardiology, Neurology (clinical), Lysophospholipids, business, Atrioventricular block, 030217 neurology & neurosurgery, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7280756313064b9e8a9c66c62cdeca13Test


    أضف إلى المفضلة
  10. 10
    Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

    المؤلفون: Aangela Vaccaro, Antonio Giordano, Marina Elena Cazzaniga, Antonio Russo, Maddalena Barba, Emilio Bria, Corrado Ficorella, Claudio Botti, Nicla La Verde, Clara Natoli, Valentina Magri, Loretta D'Onofrio, Carlo Garufi, Ruggero De Maria, Maria Rosaria Valerio, Gennaro Ciliberto, Mario Roselli, A. Fabbri, Emanuela Magnolfi, Giuseppina Rosaria Rita Ricciardi, Patrizia Vici, Alessandra Cassano, Emanuela Risi, Isabella Sperduti, Daniele Generali, Daniele Marinelli, Vito Lorusso, Teresa Gamucci, Lorenzo Livi, Giuseppe Tonini, Antonino Grassadonia, Editta Baldini, Marco Mazzotta, Luca Moscetti, Silverio Tomao, Claudio Zamagni, Silvia Carpano, Ornella Garrone, Icro Meattini, Giuseppe Sanguineti, Eriseld Krasniqi, Lucia Mentuccia, Katia Cannita, Daniele Santini, Rossana Mirabelli, Enzo Veltri, Domenico Sergi, Aandrea Michelotti, Alice Villa, Nicola Tinari, Vincenzo Adamo, A. Botticelli, Ramy Kayal, Mirco Pistelli, Domenico Corsi, Pietro Del Medico, Rossana Berardi, Enrico Cortesi, Giacomo Barchiesi, Alain Gelibter, Ida Paris, Elisa Landucci, Pia Di Stefano, Laura Pizzuti, Paolo Marchetti, Luisa Carbognin, Francesco Giotta, A.F. Scinto

    المساهمون: Krasniqi, E, Pizzuti, L, Barchiesi, G, Sergi, D, Carpano, S, Botti, C, Kayal, R, Sanguineti, G, Marchetti, P, Botticelli, A, Marinelli, D, Gamucci, T, Natoli, C, Grassadonia, A, Tinari, N, Tomao, S, Tonini, G, Santini, D, Michelotti, A, Mentuccia, L, Vaccaro, A, Magnolfi, E, Gelibter, A, Magri, V, Cortesi, E, D'Onofrio, L, Cassano, A, Cazzaniga, M, Moscetti, L, Fabbri, A, Scinto, A, Corsi, D, Carbognin, L, Bria, E, La Verde, N, Garufi, C, Di Stefano, P, Mirabelli, R, Veltri, E, Paris, I, Giotta, F, Lorusso, V, Landucci, E, Ficorella, C, Roselli, M, Adamo, V, Ricciardi, G, Russo, A, Valerio, M, Berardi, R, Pistelli, M, Cannita, K, Zamagni, C, Garrone, O, Baldini, E, Livi, L, Meattini, I, Del Medico, P, Generali, D, De Maria, R, Risi, E, Ciliberto, G, Villa, A, Sperduti, I, Mazzotta, M, Barba, M, Giordano, A, Vici, P, Eriseld K., Laura P., Giacomo B., Domenico S., Silvia C., Claudio B., Ramy K., Giuseppe S., Paolo M., Andrea B., Daniele M., Teresa G., Clara N., Antonino G., Nicola T., Silverio T., Giuseppe T., Daniele S., Aandrea M., Lucia M., Aangela V., Emanuela M., Alain G., Valentina M., Enrico C., Loretta D., Alessandra C., Marina C., Luca M., Agnese F., Angelo Fedele S., Domenico C., Luisa C., Emilio B., Nicla L.V., Carlo G., Pia D.S., Rossana M., Enzo V., Ida P., Francesco G., Vito L., Elisa L., Corrado F., Mario R., Vincenzo A., Giuseppina R., Antonio R., Maria Rosaria V., Rossana B., Mirco P., Katia C., Claudio Z., Ornella G., Editta B., Lorenzo L., Icro M., Pietro D.M., Daniele G., Ruggero D.M., Emanuela R., Gennaro C., Alice V., Isabella S., Marco M., Maddalena B., Antonio G., Patrizia V.

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Physiology, Receptor, ErbB-2, Clinical Biochemistry, Ado-Trastuzumab Emtansine, Settore MED/06, body mass index, HER2-positive metastatic breast cancer, pertuzumab, trastuzumab emtansine, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Agents, Immunological, Aged, 80 and over, education.field_of_study, Univariate analysis, Middle Aged, Metastatic breast cancer, Progression-Free Survival, Quartile, 030220 oncology & carcinogenesis, Disease Progression, Female, Pertuzumab, medicine.drug, Adult, medicine.medical_specialty, Population, Breast Neoplasms, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Breast cancer, Settore MED/04 - PATOLOGIA GENERALE, Internal medicine, medicine, Humans, Obesity, education, Aged, business.industry, nutritional and metabolic diseases, Cell Biology, Overweight, medicine.disease, 030104 developmental biology, chemistry, Trastuzumab emtansine, MED/06 - ONCOLOGIA MEDICA, business, Body mass index

    وصف الملف: ELETTRONICO

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6023937067f522e229887a4f2040aab8Test
    http://hdl.handle.net/2108/257931Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث